According to PDS Biotechnology 's latest financial reports the company's current EPS (TTM) is -$1.62. In 2022 the company made an earnings per share (EPS) of -$1.45 a decrease over its 2021 EPS that were of -$0.64.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.62 | 11.72% |
2022 | -$1.45 | 126.56% |
2021 | -$0.64 | -32.63% |
2020 | -$0.95 | 9.2% |
2019 | -$0.87 | -96.56% |
2018 | -$25.33 | -24.62% |
2017 | -$33.60 | 24.44% |
2016 | -$27.00 | -2.51% |
2015 | -$27.70 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 34.57% | ๐บ๐ธ USA |